Close

Veracyte (VCYT) Tops Q1 EPS by 78c, Revenues Beat

Go back to Veracyte (VCYT) Tops Q1 EPS by 78c, Revenues Beat

Veracyte Announces First Quarter 2021 Financial Results

May 10, 2021 4:05 PM EDT

Total Revenue of $36.7 Million Increased 18%; Volume Grew 11% to 14,437 Tests

Completed Acquisition of Decipher Biosciences, Expanding Reach Into 7 of the Top 10 Cancers in the United States

Pivotal Validation Data for Percepta Nasal Swab Lung Cancer Test To Be Presented at ASCO

Conference Call and Webcast Today at 4:30 p.m. ET

SOUTH SAN FRANCISCO, Calif.--(BUSINESS... More